Literature DB >> 10212202

Intermolecular interactions of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.

A G Harpur1, M J Layton, P Das, M J Bottomley, G Panayotou, P C Driscoll, M D Waterfield.   

Abstract

The regulatory subunit of phosphatidylinositol 3-kinase, p85, contains a number of well defined domains involved in protein-protein interactions, including an SH3 domain and two SH2 domains. In order to investigate in detail the nature of the interactions of these domains with each other and with other binding partners, a series of deletion and point mutants was constructed, and their binding characteristics and apparent molecular masses under native conditions were analyzed. The SH3 domain and the first proline-rich motif bound each other, and variants of p85 containing the SH3 and BH domains and the first proline-rich motif were dimeric. Analysis of the apparent molecular mass of the deletion mutants indicated that each of these domains contributed residues to the dimerization interface, and competition experiments revealed that there were intermolecular SH3 domain-proline-rich motif interactions and BH-BH domain interactions mediating dimerization of p85alpha both in vitro and in vivo. Binding of SH2 domain ligands did not affect the dimeric state of p85alpha. Recently, roles for the p85 subunit have been postulated that do not involve the catalytic subunit, and if p85 exists on its own we propose that it would be dimeric.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212202     DOI: 10.1074/jbc.274.18.12323

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein.

Authors:  I Gout; G Middleton; J Adu; N N Ninkina; L B Drobot; V Filonenko; G Matsuka; A M Davies; M Waterfield; V L Buchman
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

Review 2.  Short-term regulation of the proximal tubule Na+,K+-ATPase: increased/decreased Na+,K+-ATPase activity mediated by protein kinase C isoforms.

Authors:  C H Pedemont; A M Bertorello
Journal:  J Bioenerg Biomembr       Date:  2001-10       Impact factor: 2.945

3.  Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85alpha regulatory subunit.

Authors:  K Ueki; P Algenstaedt; F Mauvais-Jarvis; C R Kahn
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

4.  Regulation of phosphoinositide 3-kinase by its intrinsic serine kinase activity in vivo.

Authors:  Lazaros C Foukas; Caroline A Beeton; Jorgen Jensen; Wayne A Phillips; Peter R Shepherd
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

5.  Computational models of tandem SRC homology 2 domain interactions and application to phosphoinositide 3-kinase.

Authors:  Dipak Barua; James R Faeder; Jason M Haugh
Journal:  J Biol Chem       Date:  2008-01-20       Impact factor: 5.157

6.  Cell activation-induced phosphoinositide 3-kinase alpha/beta dimerization regulates PTEN activity.

Authors:  Vicente Pérez-García; Javier Redondo-Muñoz; Amit Kumar; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2014-06-23       Impact factor: 4.272

7.  Phosphoinositide-3 kinase binds to a proline-rich motif in the Na+, K+-ATPase alpha subunit and regulates its trafficking.

Authors:  G A Yudowski; R Efendiev; C H Pedemonte; A I Katz; P O Berggren; A M Bertorello
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

8.  Assembly and Molecular Architecture of the Phosphoinositide 3-Kinase p85α Homodimer.

Authors:  Jaclyn LoPiccolo; Seung Joong Kim; Yi Shi; Bin Wu; Haiyan Wu; Brian T Chait; Robert H Singer; Andrej Sali; Michael Brenowitz; Anne R Bresnick; Jonathan M Backer
Journal:  J Biol Chem       Date:  2015-10-16       Impact factor: 5.157

9.  High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability.

Authors:  Lydia W T Cheung; Bryan T Hennessy; Jie Li; Shuangxing Yu; Andrea P Myers; Bojana Djordjevic; Yiling Lu; Katherine Stemke-Hale; Mary D Dyer; Fan Zhang; Zhenlin Ju; Lewis C Cantley; Steven E Scherer; Han Liang; Karen H Lu; Russell R Broaddus; Gordon B Mills
Journal:  Cancer Discov       Date:  2011-06-07       Impact factor: 39.397

Review 10.  Neomorphic mutations create therapeutic challenges in cancer.

Authors:  V Takiar; C K M Ip; M Gao; G B Mills; L W T Cheung
Journal:  Oncogene       Date:  2016-11-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.